Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Abeona Therapeutics Inc (ABEO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Abeona Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.1550 -0.0150    -0.47%
15:35:21 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 967,096
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 3.0500 - 3.2750
Abeona Therapeutics 3.1550 -0.0150 -0.47%

Abeona Therapeutics Inc Company Profile

 
Get an in-depth profile of Abeona Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

57

Equity Type

ORD

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio.

Contact Information

Address 6555 Carnegie Avenue 4th Floor
Cleveland, 44103
United States
Phone 646 813 4701
Fax -

Top Executives

Name Age Since Title
Erika F. Augustine - 2017 Member of Scientific Advisory Board
Donald A. Wuchterl 54 2021 Independent Director
Steven Gray - 2017 Member of Scientific Advisory Board
Michael Amoroso 46 2020 Chairman of the Board
Vishwas Seshadri 48 2021 President, CEO & Director
Faith L. Charles - 2021 Independent Director
Mark J. Alvino 56 2021 Independent Director
Jonathon Mink - 2017 Member of Scientific Advisory Board
John Cooper - 2017 Member of Scientific Advisory Board
Leila Alland 61 2021 Independent Director
Christine Berni-Silverstein 40 2016 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABEO Comments

Write your thoughts about Abeona Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Yaroslav Demianyshyn
Yaroslav Demianyshyn Jul 05, 2022 10:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what happened?
Dima Tanasciuc
Dima Tanasciuc Jul 05, 2022 10:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Reverse split
amri ana
amri ana Feb 08, 2022 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what a stock , from 2.5 to 0.25 a crazy dive to ***
Ken Charles
Ken Charles Feb 08, 2022 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
0.15 is even much better!
Massimiliano Filippi
Massimiliano Filippi Dec 19, 2021 12:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why are they doing a warrant??? why now?
Carlos Linares
Carlos Linares Dec 18, 2021 3:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Piece of ***** This stock was unbelievably worth about 200K back in the 80s and now not even worth 50 cents. piece of trash
David Noy
David Noy Nov 01, 2021 6:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Moon
Tom Sam
Tom Sam Oct 05, 2021 11:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A very silly report made me buy this 9 months ago with promises of how it will go to 3+. Well....
Ochem Hilary
Ochem Hilary Sep 13, 2021 4:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the movement is not encouraging
Tom Sam
Tom Sam Jul 21, 2021 5:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A silly report made me buy this.
jad kutbi
jad kutbi Jun 02, 2021 5:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
To the moon
May 25, 2021 12:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Trash stock - trash ceo!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email